4 Results for "

HIF-2α-IN-2

" in MedChemExpress (MCE) Product Catalog:
Products (4)

4 Results for "HIF-2α-IN-2" in MCE Product Catalog:

Cat. No.: HY-130264
CAS No.: 1672666-82-8
Purity:  99.93%
Research Areas:  

Cancer

HIF-2α-IN-2 is a hypoxia-inducible factors (HIF-2α) inhibitor extracted from patent WO2015035223A1, Compound 232, has an IC50 of 16 nM in scintillation proximity assay (SPA) .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-153016
CAS No.: 2750141-15-0
Purity:  99.59%
Research Areas:  

Inflammation/Immunology

HIF-2α agonist 2 (compound 10) is a HIF-2α agonist with an EC50 value of 1.68 μM at the dose of 20 μM. HIF-2α agonist 2 is non-cytotoxic against 786-O-HRE-Luc cells. HIF-2α agonist 2 can be used for oxygen metabolism research .
loading...
    loading...
Cat. No.: HY-P10221A
Research Areas:  

Cancer

Cyclo(CKLIIF) TFA is an inhibitor of HIF-1α and HIF-2α. The KD values of Cyclo(CKLIIF) TFA for the PAS-B domains of HIF1-α and HIF2-α are 2.6 μM and 2.2 μM, respectively. Cyclo(CKLIIF) TFA disrupts the protein-protein interaction between HIF-1α and HIF-1β. Cyclo(CKLIIF) TFA can be used in cancer research .
loading...
    loading...
Cat. No.: HY-W470101
CAS No.: 861212-49-9
Research Areas:  

Cancer

HIF-2α-IN-17 is a selective hypoxia-inducible factor 2α (HIF2α) inhibitor that binds to the PAS-B domain of HIF2α. HIF-2α-IN-17 disrupts the interaction between HIF2α and the molecular chaperone Hsp70, leading to proteasomal degradation of HIF2α. HIF-2α-IN-17 exhibits antitumor activity and induces apoptosis in cancer cells. HIF-2α-IN-17 is applicable for research on cancers such as clear cell renal cell carcinoma .
loading...
    loading...